1318 related articles for article (PubMed ID: 9195135)
1. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
2. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.
Eizirik DL; Sandler S; Welsh N; Cetkovic-Cvrlje M; Nieman A; Geller DA; Pipeleers DG; Bendtzen K; Hellerström C
J Clin Invest; 1994 May; 93(5):1968-74. PubMed ID: 7514190
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo.
Rydgren T; Sandler S
Eur J Endocrinol; 2002 Oct; 147(4):543-51. PubMed ID: 12370118
[TBL] [Abstract][Full Text] [Related]
4. [Establishment and application of the model of islet impaired by NO free radical released from streptozotocin].
Qian FY; Ouyang F; Fu DX; Ren TR
Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):349-52. PubMed ID: 15969020
[TBL] [Abstract][Full Text] [Related]
5. Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities.
Cipolletta C; Jouzeau JY; Gegout-Pottie P; Presle N; Bordji K; Netter P; Terlain B
Br J Pharmacol; 1998 Aug; 124(8):1719-27. PubMed ID: 9756389
[TBL] [Abstract][Full Text] [Related]
6. Identification of interleukin 1-induced apoptosis in rat islets using in situ specific labelling of fragmented DNA.
Dunger A; Augstein P; Schmidt S; Fischer U
J Autoimmun; 1996 Jun; 9(3):309-13. PubMed ID: 8816965
[TBL] [Abstract][Full Text] [Related]
7. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 1beta-mediated inhibition of arginase in RINm5F cells.
Cunningham JM; Mabley JG; Green IC
Cytokine; 1997 Aug; 9(8):570-6. PubMed ID: 9245484
[TBL] [Abstract][Full Text] [Related]
9. Melatonin protects against streptozotocin, but not interleukin-1beta-induced damage of rodent pancreatic beta-cells.
Andersson AK; Sandler S
J Pineal Res; 2001 Apr; 30(3):157-65. PubMed ID: 11316326
[TBL] [Abstract][Full Text] [Related]
10. Suppression of bank vole pancreatic islet function by proinflammatory cytokines.
Blixt M; Niklasson B; Sandler S
Mol Cell Endocrinol; 2009 Jun; 305(1-2):1-5. PubMed ID: 19433255
[TBL] [Abstract][Full Text] [Related]
11. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
[TBL] [Abstract][Full Text] [Related]
12. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
Kim CK; Rivier C
J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
[TBL] [Abstract][Full Text] [Related]
13. Interleukin (IL)-1beta toxicity to islet beta cells: Efaroxan exerts a complete protection.
Papaccio G; Graziano A; Valiante S; D'Aquino R; Travali S; Nicoletti F
J Cell Physiol; 2005 Apr; 203(1):94-102. PubMed ID: 15389634
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide inhibits IRF-1 mRNA induction and prevents IL-1 beta-induced nitric oxide synthase expression in pancreatic beta cells.
Akabane A; Kato I; Takasawa S; Unno M; Yonekura H; Yoshimoto T; Okamoto H
Biochem Biophys Res Commun; 1995 Oct; 215(2):524-30. PubMed ID: 7487987
[TBL] [Abstract][Full Text] [Related]
15. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
Reimers JI
Dan Med Bull; 1998 Apr; 45(2):157-80. PubMed ID: 9587701
[TBL] [Abstract][Full Text] [Related]
17. The combined inducible nitric oxide synthase inhibitor and free radical scavenger guanidinoethyldisulfide prevents multiple low-dose streptozotocin-induced diabetes in vivo and interleukin-1beta-induced suppression of islet insulin secretion in vitro.
Mabley JG; Southan GJ; Salzman AL; Szabó C
Pancreas; 2004 Mar; 28(2):E39-44. PubMed ID: 15028959
[TBL] [Abstract][Full Text] [Related]
18. High glucose potentiates cytokine- and streptozotocin-induced apoptosis of rat islet cells: effect on apoptosis-related genes.
Mellado-Gil JM; Aguilar-Diosdado M
J Endocrinol; 2004 Oct; 183(1):155-62. PubMed ID: 15525583
[TBL] [Abstract][Full Text] [Related]
19. NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes.
Yasuda H; Jin Z; Nakayama M; Yamada K; Kishi M; Okumachi Y; Arai T; Moriyama H; Yokono K; Nagata M
Diabetes Res Clin Pract; 2009 Feb; 83(2):200-7. PubMed ID: 19117633
[TBL] [Abstract][Full Text] [Related]
20. [The role of nitric oxide on the functional change of interleukin-1 beta and interleukin-6 induced rat pancreatic islets of Langerhans].
Chen H; Cai D; Wang M; Liu H
Zhonghua Nei Ke Za Zhi; 1999 Jul; 38(7):458-61. PubMed ID: 11798681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
